MGMT and non-small cell lung carcinoma: Interestingly, a moderate heterogeneity was observed (I2 = 47%) in the analysis between MGMT hypermethylation and NSCLC, and deletion of one study by Kim (2) et al. 33, significantly reduced the heterogeneity (I2 = 25%).